2 terminated, 1 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Chronic Leukemia: new trials by email Literature Review of Chronic Leukemia trials Research Report on Chronic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant Nivolumab (.25 mg/kg), Tocilizumab, Nivolumab (.5 mg/kg) - Acute Leukemia, Chronic Leukemia | Phase 1 | Terminated | Medical College of Wisconsin | 2 | 2018-09-14 | 2021-10-11 |
| Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells Ex vivo expanded cord blood cells - Acute Leukemia, Chronic Leukemia | Phase 1 / Phase 2 | Terminated | Singapore General Hospital | 3 | 2012-03-01 | 2015-11-30 |
| Trial of AVN-944 in Patients With Advanced Hematologic Malignancies AVN-944 capsules for oral administration - Acute Leukemia, Chronic Leukemia | Phase 1 | Completed | Vertex Pharmaceuticals Incorporated | 72 | 2006-01-01 | 2011-08-04 |
Lymphoma (2) · Myelodysplastic Syndromes (2) · Hodgkin Disease (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1) · Waldenstrom Macroglobulinemia (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Bone Marrow Diseases (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Lymphoma (1) · Neoplasms, Plasma Cell (1)
AVN 944 (1) · Nivolumab (1) · tocilizumab (1)
Medical College of Wisconsin (1) · Singapore General Hospital (1) · Vertex Pharmaceuticals Incorporated (1)
United States (2) · Singapore (1)
Nirav Shah, MD (1) · William YK Hwang, MBBS, FRCP (1)